Dr Udwadia feature in the New York Times

The 1st Indian patient to successfully undergo a lung transplant was Dr. Z F Udwadia’s patient

Dr. Udwadia’s work featured in Time Magazine’s cover story for March.

Involved in the Impulsis study (NEJM 2014) of the 1st novel ILD / IPF drug NINTEDANIB (one of only 3 Indian sites chosen). This drug reduced the decline in FVC by approximately 50% in patients on NINTEDANIB compared to placebo.

His work was featured in a documentary in Al Jazeera

The only Indian doctor to be invited by WHO, Geneva to be part of a core task force to formulate new TB treatment guidelines.

The only Indian doctor named amongst India’s top strategists.

Dr Zarir Udwadia and team are the first to describe Totally Drug Resistant TB (TDR-TB) from India.